Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry Developments

Top Articles

United States

BMI View: If successfully developed and marketed, Bristol-Myer Squibb (BMS)'s investigational combination immuno-oncology therapy will potentially be a leader in the market for skin... 2013-05-20


BMI View: The steadily growing Ecuadorian pharmaceutical market will provide revenue-earning opportunities for Takeda. However, the limited market size and low per capita spending on... 2013-03-22

BMI View: Despite the undoubted clinical and commercial success of traditional chemotherapy, demand for new targeted cancer therapies is likely to remain high. This will provide continued... 2013-03-22


United States

BMI View: The outcome of the recent compulsory licence application to manufacture a generic version of Bristol-Myers Squibb (BMS)'s Sprycel (dasatinib) will likely favour the Indian... 2013-03-19

BMI View: Bayer's strong presence in Latin America has helped the company deliver above expectation sales in 2012. However, the company did not outperform the general market in the... 2013-03-19


BMI View: The Brazilian government is determined to foster the country's capacity to develop and produce innovative products and services, as globalisation has sharpened Brazil's need... 2013-03-18


BMI View: In the aftermath of Hugo Chávez's death, increasing concerns among domestic and foreign businesses have arisen. These are directed towards the rising political... 2013-03-15

BMI View: As global macroeconomic headwinds continue to restrict medicine sales in developed markets (primarily Europe, but also the US, and to a lesser extent Japan, Australia and... 2013-03-13